The overall share of people living alone in the U.S. has been inching up, per the U.S. Census.
Why it matters: Living alone can be tough in a country built for families. And it can have consequences for mental and physical health — especially among older Americans.
Pharma and biotech deal values spiked more than 35% in 2023, per data from the London Stock Exchange Group, running counter to the broad market.
Why it matters: Health care dealmakers are primed for a busy 2024 as financing markets recover, competition heats up and drug pricing regulation takes shape.